Arcutis Biotherapeutics, Inc. (ARQT) › Operating IncomeArcutis Biotherapeutics, Inc. (ARQT) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2018: -$19.73M2019: -$43.13M2020: -$136.65M2021: -$206.53M2022: -$301.63M2023: -$241.10M2024: -$128.40M2025: -$12.23M-$12.23M2018Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$12.23M+90.5%2024-$128.40M+46.7%2023-$241.10M+20.1%2022-$301.63M-46.0%2021-$206.53M-51.1%2020-$136.65M-216.8%2019-$43.13M-118.6%2018-$19.73M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share